CAR T cells reach clinical milestone in prostate cancer-Reference-Cited by-同舟云学术

CAR T cells reach clinical milestone in prostate cancer

Published:2022-03-21 Issue:4 Volume:28 Page:635-636
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Tschernia Nicholas P.,Norberg Scott M.,Gulley James L.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.nature.com/articles/s41591-022-01742-1.pdf

Reference12 articles.

1. Narayan, V. et al. Nat. Med. https://doi.org/10.1038/s41591-022-01726-1 (2022).

2. Rosa, K. OncLive https://www.onclive.com/view/p-psma-101-elicits-encouraging-responses-in-metastatic-castration-resistant-prostate-cancer (September 2021).

3. Neelapu, S. S. Blood 133, 1799–1800 (2019).

4. Fabrizio, V. A. et al. Blood Adv. https://doi.org/10.1182/BLOODADVANCES.2021006418 (2021).

5. Dorff, T. B. et al. Clin. Cancer Res. 28, 576–584 (2022).

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in and prospects of immunotherapy for prostate cancer;Cancer Letters;2024-10

2. T-Cell redirecting bispecific antibodies: a review of a novel class of immuno-oncology for advanced prostate cancer;Cancer Biology & Therapy;2024-05-27

3. Unlocking ferroptosis in prostate cancer — the road to novel therapies and imaging markers;Nature Reviews Urology;2024-04-16

4. Low-dose carboplatin modifies the tumor microenvironment to augment CAR T cell efficacy in human prostate cancer models;Nature Communications;2023-09-02

5. Progression in immunotherapy for advanced prostate cancer;Frontiers in Oncology;2023-02-28